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a b s t r a c t
Understanding the regulatory circuitry controlling myogenesis is critical to understanding develop-
mental mechanisms and developmentally-derived diseases. We analyzed the transcriptional regulation
of a Drosophila myogenic repressor gene, Holes in muscles (Him). Previously, Him was shown to inhibit
Myocyte enhancer factor-2 (MEF2) activity, and is expressed in myoblasts but not differentiating
myotubes. We demonstrate that different phases of Him embryonic expression arises through the
actions of different enhancers, and we characterize the enhancer required for its early mesoderm
expression. This Him early mesoderm enhancer contains two conserved binding sites for the basic helix-
loop-helix regulator Twist, and one binding site for the NK homeodomain protein Tinman. The sites for
both proteins are required for enhancer activity in early embryos. Twist and Tinman activate the
enhancer in tissue culture assays, and ectopic expression of either factor is sufﬁcient to direct ectopic
expression of a Him–lacZ reporter, or of the endogenous Him gene. Moreover, sustained expression of
twist in the mesoderm up-regulates mesodermal Him expression in late embryos. Our ﬁndings provide a
model to deﬁne mechanistically how Twist can both promotes myogenesis through direct activation of
Mef2, and can place a brake on myogenesis, through direct activation of Him.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Studies utilizing a variety of model systems have demonstrated
that developmental processes are initiated and controlled through
the execution of complex transcriptional networks, that are ﬁne-
tuned through the actions of both positive and negative regulatory
mechanisms (reviewed in Davidson, 2001). Genome-scale data is
now providing unprecedented insight into the cadres of genes
whose expression is either up-regulated or down-regulated by the
transcription factors that lie at the cores of these regulatory
networks (see for example Sandmann et al., 2007). A complete
understanding of how such networks function will require a
mechanistic appreciation of how the activities of both positively
and negatively acting factors are balanced.
During myogenesis, myoblasts express regulatory molecules that
promote differentiation, however the terminal differentiation pro-
gram is restrained until cells exit the cell cycle and commence
myoblast fusion. The control of this carefully choreographed process
is a subject of intense scrutiny: in mammals, high-throughput studies
have helped to reveal a robust regulatory pathway that activates
myogenic differentiation (Cao et al., 2006; Blais et al., 2005), at the
center of which are the transcriptional activators of the MyoD and
Myocyte enhancer factor-2 (MEF2) families (Black and Olson, 1998;
Tapscott, 2005). Myogenesis is also carefully controlled by negative
regulatory input: Id proteins inhibit myogenesis through inhibiting
MyoD function (Benezra et al., 1990); and the recently-characterized
RP58 protein promotes myogenesis through transcriptional suppres-
sion of Id genes (Yokoyama et al., 2009). Clearly, understanding the
regulation and function of each of these classes of regulatory factors is
essential to gain a full appreciation of how myogenesis is controlled.
In Drosophila, a central framework for understanding the regula-
tory program of muscle development has been established through
genetic and molecular analyses. The mesoderm is ﬁrst speciﬁed by
the action of the basic, helix-loop-helix transcription factor Twist
(Leptin, 1991), which is responsible for initiating the three rounds of
cell division that take place in the developing mesoderm (Arora and
Nusslein-Volhard, 1992; Wong et al., 2014). Twist levels are modu-
lated during subdivision of the mesoderm, where high Twist levels
are required for skeletal myoblast speciﬁcation, and lower levels of
Twist permit visceral mesoderm speciﬁcation (Borkowski et al., 1995).
At the molecular level, high levels of Twist promote Twist homodimer
formation, which is sufﬁcient to promote skeletal muscle fate; by
contrast, reduced Twist levels enable formation of Twist-Daughterless
heterodimers, which suppress expression of Twist target genes and
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attenuate skeletal muscle speciﬁcation (Castanon et al., 2001; Wong
et al., 2008). By the end of embryogenesis, Twist levels in skeletal
muscles decline at the onset of their differentiation, and Twist
expression is sustained only in precursors of the adult skeletal
muscles (Bate et al., 1991).
While a decline in Twist levels correlates with the onset of
myogenesis, the role of Twist in promoting or repressing muscle
development is complex. In the Drosophila embryo, sustained
expression of Twist in skeletal myoblasts and skeletal muscles
through to the end of embryogenesis does not interfere with muscle
development, and a normal pattern of body wall muscles is gener-
ated in a high-Twist genetic background (Baylies and Bate, 1996). By
contrast, sustaining twist expression during the pupal stage, where
adult myogenesis occurs, severely inhibits muscle formation (Anant
et al., 1998). Whether these differences represent differences in the
amount of Twist induced using different promoters, or the avail-
ability of co-factors, or the existence of distinct mechanisms for
regulating myogenesis at different stages of the life cycle, is unclear.
Therefore, deﬁning at the genomic level how transcriptional activa-
tors and repressors are regulated can provide insight into how this
process is controlled at different stages of development.
Essential targets of Twist during early mesoderm development are
the genes encoding Drosophila MEF2, and the NK homeodomain
protein Tinman. Twist activates Mef2 early in embryonic development
through a conserved E-box sequence in the Mef2 enhancer (Cripps
et al., 1998; Nguyen and Xu,1998). While twist expression declines later
in embryonic development, MEF2 continues to accumulate at high
levels in myoblasts and developing muscles. At this time,Mef2 function
is essential for muscle differentiation, but not for myoblast speciﬁcation
(Lilly et al., 1995; Bour et al., 1995), and MEF2 promotes myogenesis
through direct activation of a large number of muscle structural genes
(Lin et al., 1997; Kelly et al., 2002; Sandmann et al., 2006). tinman
expression is also initially activated by Twist through a conserved 30
enhancer (Yin et al., 1997), and tinman subsequently functions to
specify dorsal mesodermal tissue including the heart, visceral muscle,
and a subset of skeletal muscles (Bodmer, 1993; Azpiazu and Frasch,
1993), through activation of a cadre of factors, many of which also
respond to Twist (Liu et al., 2009; Junion et al., 2012; Jin et al., 2013).
Given that MEF2 is a direct activator of muscle differentiation,
how is it that the earliest phase ofMef2 expression in the mesoderm,
activated by Twist, does not cause muscle differentiation in myo-
blasts? A partial explanation for this dilemma came from the work of
Liotta et al. (2007), who identiﬁed the gene Holes in muscles (Him) as
a direct repressor of MEF2 function. These authors showed that Him
expression shadowed the early phases of twist and Mef2 expression
in myoblasts, and that upon the initiation of differentiation, Him
expression levels declined. At the molecular level, it was shown that
the Him protein interfered with the transcriptional activation func-
tion of MEF2. Their ﬁndings led to a model where Him acts as an
early brake upon myogenesis; when the appropriate developmental
stage is reached, Him levels decline, and MEF2 can activate the
myogenic program. While this model has yet to be fully tested using
loss-of-function Him mutations, the strong ability of Him to inhibit
muscle formation in embryos, and its diminution in expression at the
onset of myoblast fusion, argue for Him playing an important role in
regulation of the myogenic program.
To more fully understand this regulatory pathway, we sought to
deﬁne how expression of the Him gene is regulated at the transcrip-
tional level during early mesoderm development. Prior genome-wide
chromatin immunoprecipitation studies have indicated that Himmay
be a target of Twist and Tinman (Sandmann et al., 2007; Liu et al.,
2009; Jin et al., 2013). We followed up on these studies by analyzing
in greater detail Him expression, and the activities of genomic Him–
lacZ fusion constructs, in order to identify embryonic regulatory
sequences for this gene. We found that the early mesodermal Him
enhancer is predominantly contained within a promoter-proximal
region, whereas enhancers for Him expression in other mesodermal
tissues are in more distal locations. Importantly, the proximal enha-
ncer contains two functional and conserved Twist binding sites, and
one site recognized by Tinman. Both Twist and Tin binding sites are
required in tissue culture assays for full activation of the enhancer by
Twist and Tin, respectively. Moreover, these sites are also nece-
ssary for normal enhancer activity in vivo. We also demonstrate that
Twist and Tin can activate the endogenous Him gene in vivo.
Our ﬁndings provide mechanistic insight into the brake on
myogenesis that occurs during mesoderm speciﬁcation: twist and
tin expression at early stages in turn activate the myogenic
inhibitor Him; yet, once Twist or Tin levels decline at mid-embry-
ogenesis, Him is no longer expressed in the mesoderm, and MEF2-
dependent muscle differentiation can proceed.
Materials and methods
DNA methods
Standard protocols were used for DNA manipulation, ampliﬁcation,
and puriﬁcation (Sambrook et al., 1998). Mutagenesis was carried out
using the Altered Sites mutagenesis kit (Promega Corp.). Twist and Tin
sites in theHim promoter fragment were altered to the same sequences
used for electrophoretic mobility shift competition assays (see below).
The cDNAs for Him (RE70039) and Zfh-1 (LD10638) cloned into the
vectors pFLC-1 and pBluescript SK-, respectively, were obtained from
the Drosophila Genomics Resource Center (Bloomington, IN). Him
promoter fragments were generated by PCR using genomic DNA as
template, and initially cloned into the pGEM-T Easy vector (Promega
Corp.), before being transferred into the lacZ reporter plasmids CHAB
(Thummel and Pirrotta, 1992) or placZattb (Bischof et al., 2013).
Drosophila stocks and crosses
Fly stocks were maintained at 25 1C, and crosses were carried
out using standard procedures. The stock y w was used as a non-
transgenic control. The 24B-Gal4 and 69B-Gal4 driver lines were
obtained from the Bloomington Drosophila Stock Center. UAS-twi
and twi-Gal4 lines were generously provided by Dr Mary Baylies
(Memorial Sloan-Kettering Cancer Center, NY). UAS-tin was
described in Ryan et al. (2007).
P-element mediated germline transformation was carried out
as described by Rubin and Spradling (1982), using the transform-
ing plasmid and Delta2-3 transposase source (Robertson et al.,
1988) for CHAB constructs. At least three independent lines were
analyzed for each construct. For the placZattb construct (Tin3
mut), one line was analyzed.
Immunohistochemistry and in situ hybridization
The methods of Patel (1994) were used for immunodetection of
proteins. Primary antibodies were mouse anti-ß-Gal (Promega
Corp., 1:1000 dilution), rabbit anti-Tinman (Yin et al., 1997,
1:250, generously donated by Dr Manfred Frasch, University of
Erlangen-Nuremberg, Germany), rabbit anti-MEF2 (Lilly et al.,
1995, 1:1000, generously donated by Dr Bruce Paterson, NCI,
NIH), and rat anti-Tropomyosin (AbCam Inc., 1:500 dilution).
Secondary antibodies for colorimetric detection were from the
Vectastain Elite detection kit (1:1000 dilution), and diaminoben-
zidine was used as the chromogenic substrate (Vector Labora-
tories). Fluorescent detection was using Alexa (Roche) linked
secondary antibodies (1:2000 dilution).
For colorimetric in situ hybridization to detect Him transcripts, a
Digoxigenin (Dig)-labeled antisense probe was generated from pFLC-
1/RE70039 that had been cut with EcoRI, using T3 RNA polymerase
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and Dig RNA Labeling Kit (Roche). In situ hybridization of antisense
probes to embryos was carried out as described by O’Neill and Bier
(1994). Hybridized probe was detected using horseradish peroxidase-
linked mouse anti-Dig and NBT/BCIP substrate (Roche).
For ﬂuorescent in situ hybridization detection of Him tran-
scripts, a FITC-labeled (Roche) antisense probe was generated from
pFLC-1/RE70039 cut with XhoI (to generate a smaller probe), using
T3 RNA polymerase. In situ hybridization of antisense probes to
embryos was carried out by combining the pre-hybridization
protocol speciﬁcally for embryos in Lécuyer et al.(2008) and then
following the Watakabe et al.(2010) post hybridization protocol
with TSA ampliﬁcation (Perkin Elmer).
Electrophoretic mobility shift assays
DNA binding assays were carried out essentially as described by
Cripps et al. (1998). Twist or Tin proteins were synthesized in a coupled
rabbit reticulocyte lysate transcription–translation system (Promega),
using pCITE-2a/twist (Cripps et al., 1998) and T7 RNA polymerase, or
pBluescript KS/tinman (Bodmer, 1993) and T7 RNA polymerase.
Unprogrammed lysate (lacking the expression plasmid but containing
the RNA polymerase) was used as a negative control for binding assays.
DNA probes, comprising the putative transcription factor binding sites
plus 10nt on each side of ﬂanking sequence, were generated by
annealing complementary oligonucleotides corresponding to wild-
type or mutant versions of the candidate binding sites. Probes were
radioactively labeled using Klenow enzyme (New England Biolabs) and
32 P-dCTP, to ﬁll in 50-GG overhangs designed into the oligonucleotides
that were annealed. Binding assays were carried out in binding buffer
(Lee et al., 1997 for Twist; Gossett et al., 1989 for Tin) at room
temperature for 20 min, before bound and unbound reaction compo-
nents were resolved on a non-denaturing acrylamide gel, and visua-
lized by autoradiography of the dried gel. For the competition assays,
100-fold excess of non-radioactive dsDNA oligonucleotide was used.
Mutant sequences for competitionwere as follows: for Twi5, sequences
were changed from 50-CACATGTG to 50-GAGCTCTG; for Twi6, 50-
CACATG to 50-ACTAGT; for Tin3, 50-CACTTGA to 50-GAATTC. Note that
the Twi5 site comprises two overlapping E-boxes.
Tissue culture and cotransfection analysis
Details of S2 cell culture and co-transfections are essentially as
described in Tanaka et al. (2008). The Twist expression plasmid
pPac-Twist was described in Shirokawa and Courey (1997), pPac-
Tin was created by cloning a tin cDNA from pKS-tin into pPacPl,
and pPacPl empty vector was used as a control. Reporter con-
structs were either the wild-type 336/15 Him enhancer in
CHAB; or mutated versions of the same construct, in which either
Twist or Tin sites had been mutated. The total amount of DNA for
transfection was kept constant for each reaction.
Results
Identiﬁcation of regulatory sequences required for Him transcription
The expression pattern of Him, as initially published via the high
throughput analysis of Tomancak et al. (2002) was of interest given
its prevalent expression in precursors of mesodermal cell types. As
elaborated by Liotta et al. (2007), the earliest expression of Him was
throughout the mesoderm from stages 9–10 (Fig. 1A), and enriched
in the dorsal mesoderm at stage 11 (Fig. 1B). This timing preﬁgured
muscle differentiation. By stage 14 of development, general Him
expression in the mesoderm had declined, and Him transcripts
were detected in a row of dorsal mesodermal cells corresponding to
pre-cardiac cells (Fig. 1C). At this stage, Him transcripts also were
detected in precursors of the adult skeletal muscles. This adult
skeletal muscle precursor expression persisted through to the end
of embryogenesis, as did the cardiac expression of Him (Fig. 1D).
In order to deﬁne how this dynamic pattern of Him expression
was regulated in the early mesoderm, we sought to identify
genomic sequences that might direct this activity. Him is located
on the proximal X chromosome. It is ﬂanked closely on the
proximal side by CG33639, whereas about 4 kb of upstream
sequence separates Him from the more distal regulatory gene
Her (Fig. 1E). Therefore, we initially generated by PCR a 1.5 kb
region of genomic DNA immediately upstream of the Him promo-
ter, to determine if enhancer activity for Him lay in this region.
Transgenic animals carrying a 1657/15 Him–lacZ fusion were
analyzed for ß-Galactosidase (ß-Gal) expression during embryogen-
esis. We found that this genomic region contained enhancer activity
for two of the three domains of expression identiﬁed through in situ
hybridization. Firstly, there was enhancer activity for robust early
mesoderm expression (Fig. 1F), where the initiation of expression
mirrored closely the endogenous expression of Him. To determine if
this enhancer activity was throughout the early mesoderm, we co-
stained Him–lacZ embryos for accumulation of ßgal and the
mesodermal marker MEF2. We observed essentially complete over-
lap between the two epitopes, indicating that the earliest Him–lacZ
expression was throughout the nascent mesoderm (Fig. 1F’–F”’).
Secondly, expression of the lacZ reporter was observed in the
dorsal mesoderm at stage 11 (Fig. 1G) and continuing in the dorsal
mesoderm through stage 14 (Fig. 1H) and in the developing dorsal
vessel at later stages (Fig. 1I). To assess if the early dorsal mesoderm
expression corresponded to cardiac precursor cells, we double-stained
Him–lacZ embryos for ßGal and Tin. Here, we observed a subset of
ßGal-positive cells co-expressing tin in a dorsal location consistent
with the cardiac precursors. Tin-positive cells in a slightly more ventral
and internal location corresponding to visceral mesoderm did not
accumulate ßGal (Fig. 1G’–G”’). We also assessed the later expression
of Him–lacZ in the dorsal vessel, to determine if the reporter showed
differential expression between cardial and pericardial cells. In this
instance, there was weak co-accumulation of ßGal with MEF2-positive
cardial cells, and stronger ßGal accumulation in pericardial cells
(Fig. 1I). This ﬁnding conﬁrmed the observations of Ahmad et al.
(2014), who showed activity of a Him–lacZ reporter in pericardial cells
and not cardial cells.
Based upon these observations, we concluded that the 1657/
15 region contained enhancer activity for early mesodermal and
cardiac expression of Him in the embryo. Interestingly, we did not
observe adult muscle precursor cell expression of the Him–lacZ
construct, neither during embryogenesis nor during larval develop-
ment (data not shown). Since Soler and Taylor (2009) have shown that
a 4 kb Him promoter–GFP fusion is active in the adult muscle
precursors, we conclude that enhancer activity for this expression
domain lies upstream of position 1657. In summary, we identiﬁed
regulatory sequences controlling two major aspects of Him expression.
Separable enhancers control Him expression in early mesoderm and
cardiac cells
Having broadly localized the early mesodermal enhancer of Him,
we next sought to narrow down the sequences responsible for this
activity. To guide us in designing suitable constructs, we hypothe-
sized that Him might be a direct transcriptional target of Twist and/
or Tin. This hypothesis was based upon the early mesodermal
expression of twist and tin, plus high throughput analyses demon-
strating that a chromatin near the Him early mesodermal enhancer
could be immunoprecipitated by both Twi and Tin antibodies
(Sandmann et al., 2007; Liu et al., 2009; Jin et al., 2013). We
assessed the 1657/15 region for consensus Twist and Tin
binding sites (Lee et al., 1997 for Twist; Chen and Schwartz, 1995
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for Tin). We found six putative Twist sites in this region (termed
Twi1–6) and three putative Tin sites, designated Tin1–3. These sites
are annotated in Fig. 2, adjacent to the enhancer activity of the full-
length 1657/15 construct (Fig. 2A and B).
Through analysis of 50 deletions of the full-length construct, we
found that the most proximal region of the enhancer was
responsible for the majority of early mesodermal enhancer activ-
ity. Firstly, a 50-deletion of 1000 bp from the original enhancer,
to create 589/15 Him–lacZ, did not affect early mesodermal
lacZ expression, although this deletion did remove the dorsal
mesoderm and later cardiac enhancer activity (Fig. 2C, D). Since
the 589/15 fragment contained four consensus Twist binding
sites and one Tin site, we generated a further deletion, 336/15,
that contained only the Twi5, Twi6, and Tin3 sites. This construct
also showed strong mesodermal expression, but no expression in
the cardiac tissue in later embryos (Fig. 2E, F).
We complemented the 50 deletion studies with analyses of the
activities of 30 deletions of the original construct. The 1657/
1016 enhancer–lacZ construct showed only weak activity in the
early mesoderm (Fig. 2G), but retained dorsal mesoderm and
cardiac enhancer activity (Fig. 2H). A larger construct, 1657/
311, did not show any signiﬁcant increase in enhancer activity
over the other 30 deletion construct, either at early stages or later
in development (Fig. 2I and J).
These studies deﬁned two separable genomic regions that were
sufﬁcient for Him–lacZ expression during embryogenesis. More
distally, an enhancer controls expression in the dorsal mesoderm
and dorsal vessel from stage 11 onwards, and this region co-localizes
with two of the three consensus Tin binding sites. More proximally,
an enhancer controls the early broadmesoderm phase of expression.
While distal regions show some early mesoderm enhancer activity
(see panels G and I in Fig. 2) the predominant determinant of
mesodermal expression lies in the region 336/15.
Twist and Tin bind speciﬁcally to conserved promoter-proximal sites
To provide molecular context to the deletion studies, we next
sought to determine if Twist and Tin were capable of binding to
any of the consensus sequences that we identiﬁed. This was
carried out through electrophoretic mobility shift assays, using
proteins synthesized in vitro, and radioactively labeled probes
corresponding to the putative sites.
In an initial analysis, we assessed the ability of all six putative
Twist sites from the 1657/15 element to interact with Twist
protein (data not shown). Two sites showed particularly strong
interactions: Twi5 and Twi6. These are also the sites that were
contained within the most proximal genomic fragment, that
corresponds to the early mesodermal enhancer activity. Of the
remaining sites, Twi1 showed interaction with Twist, whereas the
association of Twist with the remaining sites (Twi2–4) was either
modest or undetectable.
In order to characterize the interaction of Twist with the Twi5
and Twi6 sites, we carried out DNA binding assays that also
included competitor oligonucleotides (Fig. 3A). When challenged
with non-radioactive wild-type competitor, the binding of Twist to
radioactive Twi5 or Twi6 oligonucleotides was signiﬁcantly dimin-
ished (lanes 3 and 7, respectively), as compared to the interaction
observed in the absence of competitor (lanes 2 and 6,
Fig. 1. Expression, organization, and regulation of the Him locus in Drosophila. A–D: Expression of Him during embryogenesis, as detected using a Him antisense riboprobe.
A: Him transcripts were readily detected at stage 10 throughout the mesoderm (ms). B: At stage 11, Him was expressed in skeletal muscle myoblasts (sm), and showed
enrichment in the dorsal mesoderm (dm); C: By stage 14, Him transcripts were not detected in developing muscles, but were visible in adult muscle precursor cells (ampc)
and the dorsal vessel (dv); D: At stage 15, signal persisted in the dorsal vessel and in the adult myoblasts (out of plane of focus). No speciﬁc in situ hybridization signal was
obtained with a control sense probe (not shown). E: GBrowse image from FlyBase (Grumbling and Strelets, 2006; url: http://ﬂybase.bio.indiana.edu/) depicting the genomic
region of Him (lighter blue box, highlighted in salmon; adjacent genes are indicated in darker blue). The red line indicates the genomic region tested for enhancer activity. F–
J: Anti-ß-Galactosidase stains of embryos transgenic for the 1657/15 Him–lacZ transgene (see text for more details). F: Him–lacZ activity was strong at stage 10 in a broad
swath of mesodermal cells. F’–F”’: Double-labeling of Him–lacZ embryos for ßGal (green) and MEF2 (red) accumulation showed close overlap in expression, indicating that
the Him–lacZ was expressed broadly in the mesoderm. G: In stage 11 embryos, Him–lacZ was expressed in skeletal muscle myoblasts and the dorsal mesoderm. G–G”’:
Double-labeling of Him–lacZ embryos for ßGal (green) and Tin (red) accumulation conﬁrmed their close overlap in expression in the pre-cardiac mesoderm (cm) but not in
the visceral mesoderm (vm). H: At stage 14, Him–lacZ expression was also observed in the developing cardiac tissue. There was also persistent ß-Gal detected in the
developing skeletal muscles, which most likely represents perdurance of the reporter protein from earlier stages, rather that Him–lacZ transcription at this stage. I: At stage
15, the skeletal muscle stain had reduced, and the dorsal vessel stain was still strong. J: At stage 16, Him–lacZ expression in the cardiac tube was predominantly restricted to
MEF2-negative pericardial cells. Embryos are oriented with anterior to the left; A, B, C, F, G and H are sagittal views; D, I and J are dorsal views. Bar, 100 mm.
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respectively). In addition, the competition for binding was atte-
nuated when mutant oligonucleotide competitors were used
(lanes 4 and 8).
We carried out a similar experiment to determine if Tin could
bind speciﬁcally to Tin3 (Fig. 3B). Here, we found that Tin could
bind to the consensus sequence in vitro (lane 2), and that the
binding could be effectively competed with an unlabeled wild-
type Tin site (lane 3), but not by an unlabeled mutant Tin site
(lane 4).
Taken together, these data indicate that the Him proximal
genomic fragment contains sequence-speciﬁc binding sites for
the regulatory proteins Twist and Tin. We suggest that the more
distal Twist sites, most likely Twi1, are responsible for the weak
early mesodermal activity that we documented for the constructs
with 30 deletions.
We studied the Him promoter of related Drosophila species to
determine if the Twist and Tin sites were conserved. We found
that Twi5 and Tin3 sequences were 100% conserved in the
upstream region of Him orthologous genes in all tested species
from D. melanogaster to D. grimshawi (Fig. 3C). Twi6 was also
conserved from D. melanogaster to D. erecta, but less so in more
distantly-related species. We also noted that other upstream
sequences were conserved between species, that are additional
to those that probably interact with the basal transcription
machinery. This suggests that further transcription factors might
regulate the Him mesodermal enhancer. Nevertheless, the
sequence conservation suggested that the Twist and Tin sites were
functionally important to Him regulation, thus we next tested
whether the enhancer could be activated by Twist or Tin via
these sites.
Twist and Tin activate the Him enhancer dependent upon the
presence of their binding sites
To more thoroughly investigate the role of Twist and Tin in
activation of Him transcription, we determined if we could repro-
duce the activation in tissue culture cells. We ﬁrstly co-transfected
into Drosophila S2 cells an expression plasmid for Twist, plus the
336/15 Him–lacZ reporter. We observed consistent activation of
the Him–lacZ construct, as compared to a control transfectionwhere
empty expression plasmid was substituted (Fig. 4A, blue bars). To
determine if the activation of Him–lacZ occurred via Twist binding
to the consensus sequences that we had characterized, we tested
the ability of Twist to activate a version of the Him–lacZ reporter in
which both of the Twist sites had been mutated (termed 336/
15 2XTwi-mut). In this instance, Twist was unable to activate
expression of the lacZ reporter (Fig. 4A, red bars).
In a similar experiment, we observed that Tin was able to
activate the Him–lacZ reporter in S2 cells. Mutation of the
conserved Tin site attenuated reporter activity in response to Tin,
although did not completely abolish activation of the reporter by
Tin (Fig. 4B). This suggested that some additional sequences in the
promoter region might function as Tin sites, although inspection of
the sequence did not reveal further sequences that were close
matches to the Tin binding consensus.
To determine if the Twist or Tin binding sites were required
in vivo for enhancer activity, we next determined if these mutated
versions of the enhancer could direct lacZ expression in transgenic
embryos. In comparison to the wild-type enhancer lacZ (Fig. 4C),
enhancers carrying either the mutated Twist sites or the mutated
Tin site were unable to activate lacZ expression in the early
mesoderm of transgenic animals (Fig. 4D, E). Thus, even though
the tissue culture data indicated that Tin could activate Him–lacZ
even with Tin3 mutated, Tin3 was essential for enhancer activity
in the early mesoderm in vivo. Interestingly, mutation of Tin3 also
relieved some repression of the enhancer at later stages of
development, since 336/15 Tin-mut Him–lacZ transgenic
embryos showed high levels of lacZ expression as late as stage
15 (Fig. 4E, inset).
We also determined if the functions of the endogenous twist
and tin genes were required in embryos for expression of the
endogenous Him gene. In comparison to the strong Him expression
in control embryos at stage 10 (Fig. 4F), we found that in twist
mutant embryos, there was a lack of Him transcripts (Fig. 4G). We
note that this result is somewhat difﬁcult to interpret, since twist
mutants do not form a mesoderm (Leptin, 1991), yet the result is
Fig. 2. Enhancer activity of Him–lacZ transgenic constructs. Embryos carrying the indicated enhancer–hsp–lacZ constructs (to the left) were stained for ß-Galactosidase
accumulation. Note that the constructs also show the locations and the presence/absence of consensus Twist and Tin bindings sites (Twi1–Twi6, Tin1-3). A, B: As indicated in
Fig. 1, the 1657/15 region contains enhancer activity for skeletal myoblast (sm) and dorsal vessel (dv) expression of Him. C–F: 50 truncations to either 589 (C, D) or to
336 (E,F) removed the cardiac enhancer activity, but retained the skeletal myoblast activity. G–J: 30 truncations to either 1016 (G,H) or to 311 (I,J) removed most of the
skeletal myoblast activity, but retained the dorsal vessel enhancer. All embryos are oriented anterior to the left. A, C, E, G, I: Sagittal views at stage 11; B, D, F, H, J: Dorsal
views at stages 15–16. Bar, 100 mm.
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consistent with a requirement for Twist in Him activation. In tin
mutant embryos, we observed that Him expression was down-
regulated in the mesoderm compared to controls, but Him tran-
scripts were still observed in the mesoderm (Fig. 4H).
We note that, while mutation of the Tin site in the context of the
minimal Him–lacZ reporter resulted in a failure of reporter expression
at early stages of development, tin loss of function mutants still
retained signiﬁcant mesodermal expression of Him, albeit at a reduced
level. The most reasonable explanation for this observation is that
sequences additional to the minimal construct also contribute to a
lower level of early mesodermal expression of Him, and that these
sequences function independently of Tin. Overall, our data demon-
strated that Twist and Tin are critical to fully activate Him sequences in
tissue culture cells and in the early Drosophila mesoderm, and that
sequences overlapping the Tin binding site may also function later in
development to aid in suppression of Him expression.
Fig. 3. Twist and Tin bind speciﬁcally to conserved sites in the Him promoter. A: An electrophoretic mobility shift assay showed that Twist protein complexed with
radioactively labeled dsDNA corresponding to Twi5 (lane 2) and Twi 6 (lane 6). The speciﬁcity of these interactions was assessed through competition assays. In both cases,
the bound probe complex was competed using non-radioactive wild-type (wt) sequence (lanes 3 and 7), but was not competed with non-radioactive mutant (mt) sequence
(lanes 4 and 8). B: Electrophoretic mobility shift assay demonstrated that Tin protein could bind to dsDNA corresponding to Tin3 (lane 2), and that this interaction was
competed by addition of non-radioactive excess of wild-type competitor (wt, lane 3), but not by addition of non-labeled mutant competitor (mt, lane 4). C: Sequence
comparison of the promoter regions of Him genes from related Drosophila species (in order, D. melanogaster, D. sechellia, D. erecta, D. pseudoobscura, D. virilis, and D.
grimshawi). Note that Twi5 and Tin3 are strongly conserved, and Twi6 is conserved across more closely-related species to D. melanogaster. The A nucleotide corresponding to
the transcription start site is labeled in green (TSS).
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Twist and Tin can activate Him expression in vivo
Given the requirements of twi and tin function for activation of
Him expression, we next determined if either of these regulators
were sufﬁcient to promote Him expression in vivo. Initially, we
determined if Twist or Tin could activate expression of the 1657/
15 Him–lacZ transgene in embryos. We generated embryos
carrying the ectodermal driver 69B-Gal4, the 1657/15 Him–
lacZ transgene, and UAS constructs for either twi or tin. Embryos
were stained for accumulation of MEF2 to label the mesoderm,
and ßGal to assess reporter activity.
Control embryos showed MEF2 and ßGal accumulation in the
mesoderm and no accumulation of either protein in the ectodermal
layer (Fig. 5A–A”). Upon ectopic expression of twi in the ectoderm,
there was a dramatic expansion of the expression of bothMef2 and the
lacZ reporter (Fig. 5B–B”). We attribute expansion of Mef2 expression
to the prior demonstration that Twist is an activator of Mef2 in the
early embryo (Cripps et al., 1998; Nguyen and Xu, 1998). More
importantly, there was an expansion of Him–lacZ expression in
response to ectodermal Twist, which we attribute to a direct role for
Twist in activating Him expression. To a lesser extent, ectopic expres-
sion of Tin also activated the Him–lacZ reporter in vivo (Fig. 5C–C”),
supporting a positive role for Tin in activation of Him sequences.
In parallel, we also determined if ectopic Twist or Tin could
activate expression of the endogenous Him gene. We crossed 69B-
Gal4 to UAS-twi or UAS-tin lines, and assayed Him expression by
ﬂuorescent in situ hybridization of control and experimental
genotypes. Once again, while expression of Him was restricted to
the mesoderm in control animals (Fig. 5D), Him expression was
strongly expanded to the ectoderm in 69B4twi embryos (Fig. 5E),
and also expanded in 69B4tin embryos (Fig. 5F).
The observation that each activator can induce ectopic expres-
sion of Him in the embryo is consistent with the hypothesis that
Twist and Tin are direct activators of Him. An alternative explana-
tion is that Twist and Tin each activate other regulators, which in
turn promote Him or Him–lacZ expression. However, we feel that
when the ectopic expression data is considered in conjunction
with our earlier biochemical, tissue culture, and mutant assays,
there is compelling support for the central hypothesis that Twist
and Tin act directly to promote Him expression.
Effects of sustained expression of twist in the mesoderm
We considered the ability of Twist to strongly activate Him
expression in the ectoderm alongside two existing studies of gene
regulation in muscle development. On the one hand, Baylies and
Bate (1996) had shown that sustained expression of twist did not
inhibit skeletal muscle differentiation; by contrast, Liotta et al.
(2007) had shown that sustained expression of Him caused inhibi-
tion of muscle development. If, as we show here, Twist can activate
Him, sustained expression of twist in the mesoderm should activate
Him and thereby cause a failure of muscle differentiation.
We therefore crossed the strong mesodermal driver strain twi-
Gal4; 24B-Gal4 to a strain that carried UAS-twi transgenes on both the
X and second chromosomes, and assessed Him expression in control
and over-expression embryos. Whereas control embryos at stage 16
showed Him expression only in the dorsal vessel and adult muscle
precursor cells (Fig. 6A, ampc), twiþ24B4twi embryos showed an
Fig. 4. Activation of Him–lacZ and Him is dependent upon Twist and Tin. A: Expression plasmids containing either no cDNA (Empty vector) or twist cDNA (pPac-Twist) were co-
transfected into Drosophila S2 cells alongside Him–lacZ reporter constructs. Twist activated the wild-type 336/15 Him–lacZ; Twist did not activate the 336/15mut Him–
lacZ, in which the Twist binding sites had been mutated. B: Similarly, transfection of a tin expression plasmid (pPac-Tin) alongside Him–lacZ resulted in activation of reporter
gene expression, and this activation was reduced when the Tin site was mutated. Error bars represent standard error of the mean activation from experiments performed in
triplicate (A) or duplicate (B). C–E: Activities in vivo of transgenic embryos carrying the indicated wild-type and mutated reporter constructs, visualized by accumulation of ßGal
(brown stain). Note that, whereas the control construct showed reporter expression in the skeletal myoblasts (panel C, sm), mutation of either the Twist sites (D) or the Tin site
(E) ablated Him–lacZ expression in the embryonic mesoderm of stage 10 embryos (arrowheads). Inset in E: the Tin3mut Him–lacZ reporter showed ectopic late expression in
stage 14 embryos. F–G: Him expression levels revealed by in situ hybridization for Him transcripts in the indicated genotypes. Note that skeletal myoblast Him expression at
stage 10 is strong in control embryos (F) is lost in twist mutants (G, arrowhead), and reduced in tin mutant embryos (H, arrowhead). Bar, 100 mm.
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expansion of Him expression in the mesoderm (Fig. 6B, arrowheads).
This further conﬁrmed that Twist could activate Him, although the
degree of expansion in Him expression was much weaker than the
expansion of Him expression in the ectoderm.
To assess the effects of this increased Him expression upon
skeletal muscle formation, we also stained embryos for accumula-
tion of MEF2 and the muscle marker Tropomyosin. Control
embryos at stage 16 showed the normal stereotypical pattern of
body wall muscles (Fig. 6C), but in twiþ24B4twi embryos, there
was some derangement in the number and regularity of body wall
muscles (Fig. 6D). In particular, we observed unfused myoblasts
and muscles with defective shapes (arrowheads).
Altogether, these studies demonstrated that sustained expression
of twist could mildly impact skeletal muscle differentiation in the
Drosophila embryo. Moreover, the expanded accumulation of Him
transcripts in the mesoderm of twiþ24B4twi embryos suggests that
at least part of the effects upon skeletal muscle formation might
occur through the documented ability of Him to inhibit muscle
differentiation (Liotta et al., 2007). However, it is likely that in this
situation Twist activates other genes that may also affect normal
muscle development (addressed in greater detail in Discussion).
Discussion
In this study, we set out to identify the mechanisms through
which early mesodermal expression of the Him gene was regu-
lated. Him was characterized as being expressed in myoblasts but
not differentiating muscles. In myoblasts, Him protein can act as
an inhibitor of muscle differentiation, through inhibiting the
activity of MEF2 (Liotta et al., 2007). Him therefore lies at a critical
juncture in the muscle development program, where it can
function to retain myoblasts in an undifferentiated state until the
appropriate myogenic cues are received. Thus, understanding how
Him expression is regulated will provide insight into how this
important step in the myogenic pathway is controlled.
Transcriptional regulation in myoblasts during early mesoderm
development
We demonstrated that Him expression is activated by the bHLH
transcription factor Twist and the NK homeodomain factor Tinman
during early mesoderm development. Although this is not the ﬁrst
identiﬁed dual target of Twist and Tin (see for example Halfon et al.,
2000; Busser et al., 2012), the signiﬁcance of our ﬁndings are that
they add mechanistic detail to help clarify a long-standing dilemma
in the ﬁeld: whilst Twist is an activator of Mef2 transcription at
stages 8–9 of embryogenesis (Cripps et al., 1998; Nguyen and Xu,
1998), and MEF2 is essential for muscle differentiation (Lilly et al.,
1995; Bour et al., 1995; Sandmann et al., 2006), the onset of
myogenic differentiation does not occur until approximately stage
12 (Kelly et al., 2002). How is it that MEF2 function is held in check
prior to stage 12, and how is that check released?
Liotta et al. (2007) provided insight into this problem when they
demonstrated that Him, whose expression overlaps with twist,
encodes a protein that could inhibit MEF2 transcriptional ability. We
provide further detail into this process, by demonstrating that Him
expression responds directly to Twist function. Thus, prior to stage 12,
Twist activates both Him and Mef2, and MEF2-dependent myogenesis
is held in check by the presence of Him protein. Later in embryogen-
esis, Twist levels decline. At this time, Him is not activated and MEF2 is
released to initiate myogenesis. The loss of Him expression at this stage
may simply result from a reduction in the levels of the activating Twist
protein; alternatively, reduced Twist levels might promote the forma-
tion of Twist-Daughterless heterodimers (Castanon et al., 2001), that
could actively suppress Him expression. By this stage of development,
Mef2 transcription can be sustained because later expression of MEF2
depends upon other enhancers that are not responsive to Twist
(Nguyen and Xu, 1998; Duan et al., 2001; Cripps et al., 2004). twist,
Him and Mef2 therefore form a robust transcriptional network, that
can regulate early myogenic decisions.
In mammals, Twist also acts as an inhibitor of muscle develop-
ment, albeit in this instance through direct interaction with MEF2
factors: over-expression of M-Twist in developing myotubes
Fig. 5. Twist and Tin can ectopically activate Him–lacZ and Him expression in vivo. A–C: Him–lacZ embryos were either control (A), or subjected to ectodermal expression of twi
(B) or tin (C). Individual channels of single confocal slices are shown visualizing accumulation of MEF2 (red, A, B, C), ßGal (green, A’, B’, C’), and overlay of MEF2 plus ßGal (A”, B”, C”).
Note that in control animals, MEF2 and ßGal accumulationwere restricted to the mesoderm (ms, bracketed in A) and absent from the ectoderm (ect). In experimental animals ßGal
accumulation was observed in the ectoderm (bracketed in panels B and C). D–F: Expression of the endogenous Him gene visualized by ﬂuorescent in situ hybridization to control
animals (D), and those ectopically expressing either twi (E) or tin (F). Note that Him transcripts are excluded from the ectoderm in control samples (bracket in D), but expanded into
the ectoderm in the experimental animals (brackets in E and F). All embryos shown are stages 10–11, sagittal views. Bar, 25mm for A–C, 100 mm for D–F.
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attenuates myoblast fusion and myotube differentiation (Hebrok et
al., 1994). Moreover, M-Twist achieves this effect through direct
interaction with MEF2, and by inhibiting the transcriptional activa-
tion function of MEF2 (Spicer et al., 1996). Whether M-Twist
promotes expression of inhibitors of muscle differentiation, as does
Drosophila Twist through activation of Him, is yet to be determined.
Nevertheless, support for conserved molecular activities of Twist
proteins comes from the observation that Drosophila Twist also
directly interferes with the function of murine MEF2 (Spicer et al.,
1996).
Our ﬁndings also underscore the important roles played by
repressors of the muscle differentiation program in the correct
timing of muscle differentiation. There is now convincing evidence
that myogenesis is held in check during early mesoderm develop-
ment, through the actions of proteins that directly interact with
myogenic factors (see for examples Ling et al., 2012). The classical
example of this is the helix-loop-helix factor Id, that dimerizes with
MyoD and related factors, and prevents it from binding to DNA and
activating the expression of muscle target genes (Benezra et al.,
1990). Recent data indicate that Id genes themselves are under
negative control at the onset of myogenesis (Yokoyama et al., 2009).
The ability of Twist to inhibit myogenesis in Drosophila
Another conundrum in the regulation of Drosophila myogenesis is
that sustained expression of Twist does not inhibit muscle differentia-
tion in the embryo (Baylies and Bate, 1996), yet Twist is a negative
regulator of myogenesis during formation of the adult muscles in the
pupal stage (Anant et al., 1998). Here, we show that maintaining twist
expression fails to fully activate Him expression in the mesoderm, and
much of embryonic skeletal muscle development can proceed nor-
mally. In interpreting this result, we note that even when using very
high levels of Twist, we were not able to induce high levels of
mesodermal expression of Him, despite being able to strongly induce
Him expression in the ectoderm. In particular, in twiþ24B4twi
embryos, the expression of Him in its normal locations (the adult
muscle precursor cells and the dorsal vessel) was still greater than the
induced levels of Him elsewhere in the mesoderm. This is presumably
why sustained expression of twi in the embryo does not inhibit muscle
differentiation as strongly as it does in the adult musculature. While
the modest induction of Him expression by Twist might reﬂect use of a
weak Gal4 driver, this seems unlikely given our use of a combination of
drivers that function at high levels broadly throughout mesoderm
development. Instead, a more reasonable explanation might be that
there are mesodermal factors that are expressed in embryos stage 14
onwards, that inhibit Him expression. Although we have no direct
proof of this model, we note that mutation of the Tin site in the
minimalHim enhancer enabled reporter gene expression at later stages
of development than the control enhancer–lacZ. Therefore, this site
also appears to be a focus of negative transcriptional control of Him.
There was some derangement in the muscle pattern of embryos
with sustained Twist expression, which might be accounted for by
the established role of Him as a myogenic repressor (Liotta et al.,
2007). This interpretation is likely to be an over-simpliﬁcation,
however, since there are numerous genes encoding regulatory
factors that are bound by Twist in vivo (Sandmann et al., 2007).
Therefore, the effects upon muscle differentiation that we observe
may arise from the combined expression of Him plus other factors.
For example expression of Zfh-1, which encodes a zinc ﬁnger and
homeodomain-containing protein, is known to repress muscle
differentiation (Postigo et al., 1999) and is an in vivo target of Twist
and Tin (Sandmann et al., 2007; Liu et al., 2009). In addition, it is
possible that forced twist expression in the mesoderm can impact
patterns of founder cell speciﬁcation and muscle organization
separately from an effect of Him upon MEF2 function.
Gain-of-function studies with Him would ideally be complemented
with loss-of-function studies, as such studies would more effectively
test the existing models describing roles for Him in regulating the
myogenic program. In adult myogenesis, knockdown ofHim expression
using RNAi causes mild defects in the pattering of adult muscles (Soler
and Taylor, 2009), although themechanistic basis of this phenotype has
not been investigated in detail. Loss-of-function studies might also be
complicated by the presence of other myogenic inhibitors with over-
lapping functions to Him, such as Zfh1, necessitating multiple knock-
downs or knockouts for a strong phenotype to be revealed.
Him transcription is controlled by multiple distinct enhancers
Him is expressed in other mesoderm derivatives during devel-
opment, and our studies also located the enhancer for cardiac
expression of Him, in a more promoter-distal location relative to
the early mesoderm enhancer. Approximately 600 bp of DNA in
this region carries cardiac enhancer activity that resides predomi-
nantly in the pericardial cells (see also Ahmad et al., 2014), and
Fig. 6. Sustained mesodermal expression of twimaintains Him expression at later stages of embryogenesis. A, B: Stage 15 embryos from control (A) and those expressing twi
under the control of the 24Bþtwi-Gal4 driver, were stained for Him expression using ﬂuorescent in situ hybridization (green). A: Control embryos showed Him transcripts in
adult muscle precursor cells (ampc) and the dorsal vessel (dv). B: Sustained twi expression in the mesoderm resulted in expanded Him–lacZ expression (arrowheads). C, D:
Stage 16 embryos, from control and those expressing twi under the control of the 24Bþtwi-Gal4 driver, were stained for the accumulation of MEF2 (red) and Tropomyosin
(green), to assess muscle differentiation. C: Control embryos showed the stereotypical pattern of body wall skeletal muscles (sm, arrow). D: Sustained twi expression still
permitted signiﬁcant muscle differentiation, yet some defects in muscle formation were observed, including mis-shapen muscles and unfused myoblasts (arrowheads). Bar,
100 mm.
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some insight into how this area may be regulated comes from
analysis of the sequence that contains two consensus Tinman
binding sites in this region. Since paired Tin sites are a common
feature of Tin-dependent cardiac enhancers (Gajewski et al., 1997;
Cripps et al., 1999; Kremser et al., 1999; Akasaka et al., 2006;
Hendren et al., 2007; Ryan et al., 2007), the two Tin sites upstream
of Him could signify the location of the core cardiac enhancer.
Interestingly, Notch signaling represses Him expression in the
cardial cells (Ahmad et al., 2014). The role of Him in cardiac
development has not been investigated.
We have not located the enhancer for Him that acts in the adult
muscle precursor cells. However, two recent studies provide speciﬁc
insight into the location of this enhancer. Soler and Taylor (2009)
recently showed that a 4 kb promoter-proximal region of Him can
direct expression of a GFP reporter in the adult muscle precursors.
Since our longest construct extends to 1657, the adult myoblast
enhancer must be located between approximately 4000 and 1657.
In support of this argument, Bernard et al. (2010) recently found that
in DmD8 cells, a stable cell line derived from wing imaginal discs,
Twist protein co-precipitated with DNA located upstream of the Him
gene. Both of these lines of evidence suggest that the proximal
sequences are the location of the adult myoblast Him enhancer.
It is interesting to note that the expression of Him in adult
muscle precursors is controlled by an enhancer distinct from that
controlling expression in the embryonic muscle precursors. This is
certainly not the case for Mef2, where the 175 bp Mef2 enhancer is
active in both embryonic and adult myoblasts (Cripps et al., 1998).
However, there are also clear differences in the proﬁles of expres-
sion for Mef2 and Him in adult myoblasts, since Mef2 expression in
adult myoblasts is not strongly activated until late in larval life
(Lovato et al., 2005) and Him expression is observed in adult muscle
precursors in the embryo. Identiﬁcation of the adult myoblast
enhancer for Him, and determination of how that enhancer is
regulated relative to the embryonic enhancer, potentially involving
Notch regulation (Bernard et al., 2010), will provide new insight into
how the myoblasts at different stages of development use both
common and unique means to control gene expression.
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